March 2021 updates to the website

The website has now been updated following March's LSCMMG

The following guidelines have been added/updated:

Linezolid Info Sheet - New

Neuropathic Pain Guidance - Updated (Pending changes, QA and sign off)

Gender dysphoria Information Sheet - Update

Requests from a private GIC to prescribe hormone therapy or blockade in gender dysphoria - Position Statement - New

The following Items have been updated and added to the website following the latest Joint Committee of CCGs (JCCCG) Meeting:

Domperidone - As a galactagogue for birth mothers and mothers of adopted babies

Semaglutide Tablets - for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise

Galcanezumab - for preventing migraine (TA659)

liraglutide - for managing overweight and obesity (TA664)

Upadacitinib - for treating severe rheumatoid arthritis (TA665)

Brolucizumab  - for treating wet age-related macular degeneration

Amiodarone Tablets - Arrhythmias

Dronedarone - Treatment of non-permanent atrial fibrillation (NICE TA197)

The following Items will be updated and added to the website following the next Joint Committee of CCGs (JCCCG) Meeting:

Naldemedine - for treating moderate to severe rheumatoid arthritis (TA672)

Filgotinib - for treating moderate to severe rheumatoid arthritis (TA676)

Dapagliflozin - for treating chronic heart failure with reduced ejection fraction (TA679)